Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.

Last updated on 4-10-2023 by Marie Malingreau

Public Access


Peer reviewed scientific article




This paper documents the progress of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National Institute for Health and Disability Insurance reimbursed the HPV vaccine for girls aged between 12-15 years. In December 2008, the age limit was extended to include girls up to the age of 18. In November 2008, the total number of HPV vaccines sold exceeded 530,000 doses. The number of vaccines reimbursed in Belgium, for the period November 2007-November 2008, corres…

Associated health topics:

QR code

QR code for this page URL